Glenmede Trust’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
TI
RA
Glenmede Trust's SRDX Position: Q4 2020 in Review
Glenmede Trust sold out of Surmodics (SRDX) in Q4 2020, closing a stake of 164 shares — an estimated $6K sold.
Glenmede Trust first reported a position in SRDX in Q2 2013 and held it in 22 quarters. The position peaked at $467K in Q4 2015. 140 funds tracked by Wall St. Rank hold SRDX as of Q4 2020.
- Glenmede Trust reported no remaining Surmodics position as of Q4 2020 after selling out during the quarter.
- Glenmede Trust sold 164 Surmodics shares in Q4 2020, an estimated $6K.
- Glenmede Trust first reported a position in Surmodics in Q2 2013 and held it in 22 quarters.
- Glenmede Trust's Surmodics position peaked at $467K in Q4 2015.
- 140 funds tracked by Wall St. Rank held Surmodics as of Q4 2020.
Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.